Tadalafil Tablet vs Troche
Oral tadalafil is the standard FDA-approved tablet absorbed via the GI tract. The compounded sublingual troche aims for faster onset through buccal absorption. Evidence for meaningfully faster onset is limited; the tablet remains the modern default.
Oral tadalafil tablet is the modern default — on-demand or daily low-dose — under provider review.
Sublingual troche is a niche compounded option and is not in the oMeds formulary.
Educational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Is troche meaningfully faster?
Clinical evidence does not consistently support a meaningful onset advantage for most candidates.
Why use the tablet?
Standardized FDA-approved dosing, predictable absorption, and broad availability.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment